Ranitidine products recall in Canada: nitrosamine impurity
In plain language
This recall involves various over-the-counter and prescription ranitidine drugs sold in Canada. They are being recalled because they may contain a nitrosamine impurity above acceptable levels. Do not stop taking prescription ranitidine without first consulting your healthcare provider.
What to do
- Talk to your doctor or pharmacist about alternative treatment options.
- Do not stop taking prescription ranitidine without medical advice.
- Contact your healthcare provider if you have health concerns after taking ranitidine.
- Report any health product adverse events to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential health risk due to nitrosamine impurity
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential health risk due to nitrosamine impurity
What should consumers do?
Talk to your doctor or pharmacist about alternative treatment options. Do not stop taking prescription ranitidine without medical advice. Contact your healthcare provider if you have health concerns after taking ranitidine. Report any health product adverse events to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential health risk due to nitrosamine impurity
When was this product recalled?
This product was recalled on March 11, 2022.